|
|
Arbutus Biopharma
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Onpattro sales look positive Alny stock up hugely on new results for Onpattro which has LNP licensed to Abus. I believe all LNP fees for Onpattro go to Abus not to Genevant. Abus has not reacted much (yet) |
|
|
return to message board, top of board |
